Showing results (661-670 of 1,274) with videos related to
Sort By:
Pageof 128
Veterinary and Comparative Oncology|January 4, 2022
The role of toceranib phosphate in dogs with non-mast cell neoplasia: A systematic reviewPetros Frezoulis, Aaron HarperVeterinary and Comparative Oncology|January 13, 2022
Re-irradiation of canine non-lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogsTracy L Gieger, Siobhan M Haney, Michael W NolanVeterinary and Comparative Oncology|October 22, 2022
Safety and feasibility of short course pre-operative radiation therapy followed by surgical excision for canine solid tumoursLauren Smith-Oskrochi, Brandan G Wustefeld-Janssens, Danielle Hollenbeck, et al.Veterinary and Comparative Oncology|September 30, 2022
Surgical complications following sentinel lymph node biopsy guided by γ-probe and methylene blue in 113 tumour-bearing dogsLavinia Elena Chiti, Elisa Maria Gariboldi, Roberta Ferrari, et al.Veterinary and Comparative Oncology|September 23, 2022
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogsTeresa Linder, Cory Wakamatsu, Joseph Jacovino, et al.Veterinary and Comparative Oncology|May 17, 2011
Epidermal growth factor receptor as a therapeutic target in veterinary oncologyG T Bergkvist, D A YoolVeterinary and Comparative Oncology|May 17, 2011
5-Lipoxygenase expression in benign and malignant canine prostate tissuesL A Goodman, C L Jarrett, T M Krunkosky, et al.Veterinary and Comparative Oncology|January 20, 2016
DNA damage is a feature of feline injection-site sarcomaS Kang, T Southard, K R HumeVeterinary and Comparative Oncology|January 12, 2016
1,25-Dihydroxyvitamin D3 and its analogues increase catalase at the mRNA, protein and activity level in a canine transitional carcinoma cell lineR P Middleton, R Nelson, Q Li, et al.Veterinary and Comparative Oncology|January 15, 2016
The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effectsN Holtermann, M Kiupel, J HirschbergerPageof 128